Whittaker, Sean - professor of cutaneous oncology

 

Consultant profiles

Sean Whittaker, consultant dermatologist 

Contacts

Tel: 020 7188 6375 
Email: gst-tr.skintumourdermatologyreferrals@nhs.net

Administration PA: 020 7188 6410
Email: sophia.cyrille@gstt.nhs.uk

Area of expertise: skin cancer

  • Biography

    Current posts:

    • consultant dermatologist at Guys and St Thomas', 1999 - present

    • professor of cutaneous oncology division of Genetics and Molecular Medicine King's College London, 2007 - present 

    • clinical director genetics, rheumatology, infection, dermatology and allergy directorate, 2007 - present

    • joint lead for the GRIID Clinical Academic Group King's Health Partners, 2008 - present

    • specialist CRG commissioning lead for skin cancer, 2013 - present.

    Previous posts:

    • research fellowship RPMS Hammersmith Hospital, 1987 - 1990
    • consultant dermatologist at Royal Free Hospital, 1993 - 1999

    • senior lecturer, division of Genetics and Molecular Medicine King's College London, 1997 - 2007

    • lead for skin cancer at Guys and St Thomas', 2005 - 2010

    • clinical director dermatology, allergy and sexual health directorate, 2003 - 2007

    • chairman/secretary EORTC Cutaneous Lymphoma Task Force, 1999 - 2009

    • secretary/treasurer International Society for Cutaneous Lymphomas, 2009 - 2011
    • president International Society for Cutaneous Lymphomas, 2011 - 2013.
  • Specialist interests

    • skin cancers including melanoma and cutaneous lymphomas.
  • Education and training

    • London Royal College of Physicians, FRCP, 1995
    • Postgraduate Thesis (Doctorate), MD, 1994
    • London Royal College of Physicians, MRCP, 1984

    • Manchester Medical School, MB ChB, 1981

  • Research interests

    Clinical research in primary cutaneous lymphomas:

    • development of a clinical trials platform

    • the identification of prognostic factors in cutaneous lymphomas.

    Translational research in primary cutaneous lymphomas:

    • development of molecular diagnostics

    • genetic (gene mutations and chromosomal copy number gains and losses) and epigenetic (Methylation/Acetylation/MicroRNA) abnormalities involved in dysregulation of activation and apoptotic pathways in malignant T-cells

    • mechanism of action of Histone Deacetylase (HDAC) Inhibitors in cutaneous T-cell lymphomas
    • development of biomarkers for assessment of treatment response and prognosis.

     

  • Awards

    • Neil Smith Memorial Lecturer 1996
    • FRCP 1995
    • MD 1993